MARKET

CDXS

CDXS

Codexis Inc
NASDAQ
3.030
+0.160
+5.57%
After Hours: 3.090 +0.06 +1.98% 17:49 02/23 EST
OPEN
2.900
PREV CLOSE
2.870
HIGH
3.160
LOW
2.880
VOLUME
444.69K
TURNOVER
0
52 WEEK HIGH
5.65
52 WEEK LOW
1.450
MARKET CAP
211.59M
P/E (TTM)
-2.5079
1D
5D
1M
3M
1Y
5Y
Can Low Occupancy Rate Affect Select Medical (SEM) Q4 Earnings?
NASDAQ · 5d ago
ANSYS (ANSS) to Report Q4 Earnings: Here's What to Expect
NASDAQ · 6d ago
Weekly Report: what happened at CDXS last week (0212-0216)?
Weekly Report · 6d ago
WIX Set to Report Q4 Earnings: Here's What You Should Know
NASDAQ · 02/16 12:27
Higher Visits to Soften Cost Blow for Teladoc (TDOC) Q4 Earnings
NASDAQ · 02/15 16:33
Can Low Patient Days Affect Community Health (CYH) Q4 Earnings?
NASDAQ · 02/15 16:26
Analysts’ Top Healthcare Picks: Electromed (ELMD), Codexis (CDXS)
TipRanks · 02/14 13:50
Codexis Secures Strategic Financing to Support Growth Initiatives
TipRanks · 02/13 21:35
More
About CDXS
Codexis, Inc. is an enzyme engineering company. The Company is engaged in discovering, developing and selling enzymes and other proteins. The Company commercializes its CodeEvolver enzyme engineering technology platform and products in the manufacture of small molecule pharmaceuticals. It operates through two segments: Performance Enzymes and Novel Biotherapeutics. The Performance Enzymes segment consists primarily of two focus areas: biocatalysts for the sustainable manufacturing of pharmaceuticals, and enzymes for life science applications, including genomic sequencing and nucleic acid synthesis. The Novel Biotherapeutics segment offers product candidates include enzymes that are orally administered for function in the gastrointestinal tract (GI), such as its partnered product candidates CDX-7108 for the treatment of exocrine pancreatic insufficiency and CDX-6114 for the treatment of phenylketonuria, which are both in Phase I clinical trials.

Webull offers Codexis Inc stock information, including NASDAQ: CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.